Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1869-1873
Published online before print August 18, 2005, doi: 10.1161/01.STR.0000177867.39769.cb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v36,p2329)
Right arrow All Versions of this Article:
36/9/1869    most recent
01.STR.0000177867.39769.cbv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henskens, L. H.G.
Right arrow Articles by de Leeuw, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henskens, L. H.G.
Right arrow Articles by de Leeuw, P. W.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Genetics of Stroke
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2005;36:1869.)
© 2005 American Heart Association, Inc.


Original Contributions

Associations of the Angiotensin II Type 1 Receptor A1166C and the Endothelial NO Synthase G894T Gene Polymorphisms With Silent Subcortical White Matter Lesions in Essential Hypertension

Léon H.G. Henskens, MD; Abraham A. Kroon, MD, PhD; Martin P.J. van Boxtel, MD, PhD; Paul A.M. Hofman, MD, PhD Peter W. de Leeuw, MD, PhD, FAHA

From the Department of Internal Medicine (L.H.G.H., A.A.K., P.W.d.), University Hospital Maastricht, The Netherlands; and Departments of Psychiatry and Neuropsychology (M.P.J.v.) and Radiology (P.A.M.H.), Maastricht University, The Netherlands.

Reprint requests to Abraham A. Kroon, Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail akr{at}sint.azm.nl

Background and Purpose— Silent white matter lesions (WMLs) may represent early target organ damage of the brain in patients with hypertension. Because these lesions may have a genetic background, we assessed the associations between polymorphisms of the renin-angiotensin system and the endothelial NO synthase (NOS3) genes and silent WMLs.

Methods— Ninety-three hypertensive individuals were studied. MRI of the brain was performed to obtain estimates of the total volume of subcortical and the extent of periventricular WMLs. Patients were genotyped for the angiotensinogen (M235T), the angiotensin-converting enzyme (insertion/deletion [I/D]), the angiotensin II type 1 receptor (AGTR1 A1166C), and the NOS3 (G894T) genes. A linear regression model was used to assess the relationship of these gene polymorphisms with both subtypes of WMLs.

Results— When adjusted for age, diabetes mellitus, and blood pressure, subcortical WML volume was lowest in the presence of 1 or 2 AGTR1 C alleles (unstandardized ß, –38.8 [95% CI, –66.1 to –11.4] and –112.6 [CI, –188.9 to –36.4], respectively), whereas it was highest in the presence of an NOS3 T allele (3.1 [CI, 3.6 to 58.4]). No interaction between these polymorphisms on WMLs could be demonstrated. No associations were present with the other polymorphisms, either with subcortical or periventricular lesions.

Conclusions— We found the AGTR1 A1166C as well as the NOS3 G894T polymorphisms to be associated with silent WMLs in the subcortical area.


Key Words: hypertension • nitric oxide synthase • polymorphism • renin-angiotensin • white matter




This article has been cited by other articles:


Home page
StrokeHome page
L. Paternoster, W. Chen, and C. L.M. Sudlow
Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects * Supplemental References
Stroke, June 1, 2009; 40(6): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. R. Petrella, V. S. Mattay, and P. M. Doraiswamy
Imaging Genetics of Brain Longevity and Mental Wellness: The Next Frontier?
Radiology, January 1, 2008; 246(1): 20 - 32.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli
Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS)
Stroke, December 1, 2007; 38(12): 3121 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. V. Bowler
Modern concept of vascular cognitive impairment
Br. Med. Bull., September 1, 2007; 83(1): 291 - 305.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Wilson and H. Montgomery
Impact of genetic factors on outcome from brain injury
Br. J. Anaesth., July 1, 2007; 99(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. V. Bowler and P. B. Gorelick
Advances in Vascular Cognitive Impairment 2006
Stroke, February 1, 2007; 38(2): 241 - 244.
[Full Text] [PDF]


Home page
StrokeHome page
C. Opherk, N. Peters, M. Holtmannspotter, A. Gschwendtner, B. Muller-Myhsok, and M. Dichgans
Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers
Stroke, November 1, 2006; 37(11): 2684 - 2689.
[Abstract] [Full Text] [PDF]